[中國人壽保險股份有限公司 CHINA LIFE INSURANCE COMPANY LIMITED (A joint stock limited company incorporated in the People’s Republic of China with limited liability) (Stock code: 2628) ANNOUNCEMENT OF PREMIUM INCOME Reference is made to the Company’s announcement dated 27 August 2004. The accumulated premium inco]
[中國人壽保險股份有限公司 CHINA LIFE INSURANCE COMPANY LIMITED (A joint stock limited company incorporated in the People’s Republic of China with limited liability) (Stock code: 2628) ANNOUNCEMENT OF PREMIUM INCOME Reference is made to the Company’s announcement dated 27 August 2004. The accumulated premium inco]
[Changyou.com Announces Filing of Definitive Plan of Merger for Going-Private Transaction fully-vested Because Changyou Merger Co. owns over 90% of the voting power represented by all issued and outstanding shares of Changyou, the Changyou Merger will be in the form of a short-form merger of Changyou]
[Changyou.com Announces Filing of Definitive Plan of Merger for Going-Private Transaction fully-vested Because Changyou Merger Co. owns over 90% of the voting power represented by all issued and outstanding shares of Changyou, the Changyou Merger will be in the form of a short-form merger of Changyou]
[EQUITY PURCHASE AGREEMENT Agreement Company Investor This equity purchase agreement is entered into as of April 8, 2020 (this " WHEREAS NOW, THEREFORE ARTICLE I CERTAIN DEFINITIONS DEFINED TERMS Section 1.1 Agreement " Average Daily Trading Value “ (5) Trading Days immediately preceding the respecti]
[Sinovac Announces Approval of Human Clinical Trial for a Vaccine Candidate Against COVID-19 BEIJING--(BUSINESS WIRE)-- April 14, 2020-- Sinovac Biotech Ltd. (NASDAQ:SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that the Company has obta]
[EQUITY PURCHASE AGREEMENT Agreement Company Investor This equity purchase agreement is entered into as of April 8, 2020 (this " WHEREAS NOW, THEREFORE ARTICLE I CERTAIN DEFINITIONS DEFINED TERMS Section 1.1 Agreement " Average Daily Trading Value “ (5) Trading Days immediately preceding the respecti]
[Sinovac Announces Approval of Human Clinical Trial for a Vaccine Candidate Against COVID-19 BEIJING--(BUSINESS WIRE)-- April 14, 2020-- Sinovac Biotech Ltd. (NASDAQ:SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that the Company has obta]
